Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking.

B Kramer1, M Rarey, T Lengauer

  • 1German National Research Center for Information Technology (GMD), Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin, Germany.

Proteins
|December 3, 1999
PubMed
Summary

FLEXX, a flexible ligand docking tool, successfully reproduced 46.5% of protein-ligand complexes at rank 1 and 70% within all solutions. It shows reliable performance for ligands up to 15 components.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dissecting heterogeneity in cortical thickness abnormalities in major depressive disorder: a large-scale ENIGMA MDD normative modelling study.

bioRxiv : the preprint server for biology·2025
Same author

Taking shape: A geometric morphometric analysis of the immature human palate in relation to dental eruption and growth.

Morphologie : bulletin de l'Association des anatomistes·2024
Same author

Collaborative study for the characterisation of the BINACLE Assay for <i>in vitro</i> detection of tetanus toxicity in toxoids - Part 1.

Pharmeuropa bio & scientific notes·2024
Same author

The challenge of replicating putative genetic risk factors in a population-based database.

Journal of gastroenterology and hepatology·2024
Same author

Impact of Bepanthen<sup>®</sup> and dexpanthenol on human nasal ciliary beat frequency in vitro.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2023
Same author

NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients.

European heart journal open·2023

Area of Science:

  • Computational chemistry
  • Structural biology
  • Drug discovery

Background:

  • Protein-ligand interactions are crucial in biological processes and drug development.
  • Accurate prediction of ligand binding poses is essential for rational drug design.
  • Automated docking tools aim to predict these interactions efficiently.

Purpose of the Study:

  • To evaluate the performance of FLEXX, a fully automatic docking tool for flexible ligands.
  • To assess FLEXX's accuracy and efficiency on a diverse dataset of protein-ligand complexes.
  • To investigate FLEXX's capabilities in cross-docking and virtual screening scenarios.

Main Methods:

  • Testing FLEXX on 200 diverse protein-ligand complexes from the Protein Data Bank.
  • Analyzing docking success rates based on RMSD and ligand complexity.

Related Experiment Videos

  • Performing cross-docking experiments with multiple receptor structures.
  • Conducting virtual screening of a ligand library against ten proteins.

    • Main Results:

    • FLEXX reproduced 46.5% of complexes at rank 1 (RMSD < 2 A), rising to 70% within the entire solution set.
    • Reliable docking accuracy was achieved for ligands up to 15 components (80% success).
    • FLEXX demonstrated acceptable performance in cross-docking and successfully identified original inhibitors in 8 out of 10 screening cases.

    Conclusions:

    • FLEXX is a robust and efficient automated docking tool for flexible ligands.
    • Its performance is reliable for a wide range of ligand complexities.
    • FLEXX shows promise for applications in virtual screening and drug discovery pipelines.